Drug
losartan/hydrochlorothiazide
losartan/hydrochlorothiazide is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Withdrawn2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
withdrawn250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
NCT03946514
withdrawnphase_3
Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
NCT02521246
withdrawnphase_3
Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
NCT02521233
completednot_applicable
Pharmacokinetic Interactions of Losartan and Hydrochlorothiazide
NCT01858623
Clinical Trials (4)
Showing 4 of 4 trials
NCT03946514Phase 4
Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
NCT02521246Phase 3
Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
NCT02521233Phase 3
Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
NCT01858623Not Applicable
Pharmacokinetic Interactions of Losartan and Hydrochlorothiazide
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4